Expression of Calcitonin Gene-Related Peptide in Efferent Vestibular System and Vestibular Nucleus in Rats with Motion Sickness

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Xiaocheng, Wang ^a   Zhaohui, Shi ^b   Junhui, Xue ^a   Lei, Zhang ^a   Lining, Feng ^a   Zuoming, Zhang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANISODAMINE; CALCITONIN GENE RELATED PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FACIAL NERVE; IMMUNOHISTOCHEMISTRY; MALE; MOTION SICKNESS; NERVE CELL; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VESTIBULAR NUCLEUS; VESTIBULAR SYSTEM;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DENSITOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MOTION SICKNESS; NEURONS, EFFERENT; RATS; RATS, SPRAGUE-DAWLEY; SOLANACEOUS ALKALOIDS; VESTIBULAR NERVE; VESTIBULAR NUCLEI;

EID: 84867320902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047308     Document Type: Article

References (26)

1. Shupak A, Gordon CR, (2006) Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviat Space Environ Med 77: 1213-23.
2. Buyuklu F, Tarhan E, Ozluoglu L, (2009) Vestibular functions in motion sickness susceptible individuals. Eur Arch Otorhinolaryngol 266: 1365-1371.
3. Kennedy RS, Drexler J, Kennedy RC, (2010) Research in visually induced motion sickness. Appl Ergon 41: 494-503.
4. Golding JF, (2006) Motion sickness susceptibility. Auton Neurosci 129: 67-76.
5. Zajonc TP, Roland PS, (2006) Vertigo and motion sickness. Part II: Pharmacologic treatment. Ear Nose Throat J 85: 25-35.
6. Chi FL, Wang ZM, Li KY, Wu W, (1999) Calcitonin gene-related peptide changes in efferent vestibular system during vestibular compensation. Chinese Journal of Otorhinolaryngology 34: 11-13.
7. Schrott-Fischer A, Kammen-Jolly K, Scholtz A, Rask-Andersen H, Glueckert R, et al. (2007) Efferent neurotransmitters in the human cochlea and vestibule. Acta Otolaryngol 127: 13-9.
8. Vause CV, Durham PL, (2010) Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: Findings from array analysis. Neurosci Lett 473: 163-7.
9. Mapp PI, McWilliams DF, Turley MJ, Hargin E, Walsh DA, (2012) A role for the sensory neuropeptide calcitonin gene-related peptide in endothelial cell proliferation in vivo. Br J Pharmacol 10: 1476-5381.
10. Huang J, Stohl LL, Zhou X, Ding W, Granstein RD, (2011) Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells. Brain Behav Immun 25: 787-99.
11. Kong WJ, Scholtz AW, Hussl B, Kammen-Jolly K, Schrott-Fischer A, (2002) Localization of efferent neurotransmitters in the inner ear of the homozygous Bronx waltzer mutant mouse. Hear Res 167: 136-55.
12. Kong WJ, Scholtz AW, Kammen-Jolly K, Glückert R, Hussl B, et al. (2002) Ultrastructural evaluation of calcitonin gene-related peptide immunoreactivity in the human cochlea and vestibular endorgans. Eur J Neurosci 15: 487-97.
13. Wackym PA, Popper P, Ward PH, Micewck PE, (1991) Cell and molecular anatomy of nicotinic acetylcholine receptor subunits and calcitonin gene-related peptide in the rat vestibalar system. Otolaryngology-head and Neck surgery 105: 493-510.
14. Fu J, Sun Z, Yu L, Liu L, (2003) Comparison of Four Stimulation Patterns Inducing Motion Sickness. Journal of Jilin University (Medicine Edition) 29: 35-37.
15. Jiang Z, Shen H, Yang K, Xu B, Zhou WR, (2000) Establishment of conditioned taste aversion as a motion sickness model in rat. Chin J Naut Med 7: 97-100.
16. Ohno K, Takeda N, Tanaka-Tsuji M, Matsunaga T (1993) Calcitonin gene related peptide in the efferent system of inner ear. A review. Acta Otolaryngol Suppl. 501: 16-20.
17. Thompson GC, Ross CD, Thompson AM, Byers JM, (1995) Changes in brainstem calcitonin gene-related peptide after VIIth and VIIIth cranial nerve lesions in guinea pig. Brain Res 683: 140-148.
18. Wackym PA, Popper P, Micevych PE, (1993) Distribution of calcitonin gene-related peptide mRNA and immunoreactivity in the rat central and peripheral vestibular system. Acta Otolaryngol (stockh) 113: 601-608.
19. Tanaka M, Takeda N, Senba E, Tohyama M, Kubo T, et al. (1989) Localization, origin and fine structure of calcitonin gene-related peptide-containing fibers in the vestibular end-organs of the rat. Brain Res 504: 31-35.
20. Yu XH, Cai GJ, Liu AJ, Chu ZX, Su DF, (2007) A novel animal model for motion sickness and its first application in rodents. Physiol Behav 92: 702-7.
21. Hu S, Willoughby LM, Lagomarsino JJ, Gaeger HA, (1996) Optokinetic rotation-induced taste aversions correlate with over-all symptoms of motion sickness in humans. Percept Mot Skills 82: 859-864.
22. Ohno K, Takeda N, Yamano M, Matsunaga T, Tohyama M, (1991) Coexistence of acetycholine and calcitonin gene-related peptide in the vestibular efferent neurons in the rat. Brain Res 566: 103-107.
23. Perachio AA, Kevetter GA, (1989) Coexistence of choline acetyltransferase and calcitonin gene-related peptide in vestibular efferents of the gerbil. Neurosci Abs15: 518.
24. Chi FL, Jiao Y, Liu HJ, Wang J, Shi Y, Barr JJ, (2007) Retrograde neuron tracing with microspheres reveals projection of CGRP-immunolabeled vestibular afferent neurons to the vestibular efferent nucleus in the brainstem of rats. Neuroendocrinology 85(3): 131-8.
25. Spinks AB, Wasiak J, Villanueva EV, Bernath V (2007) S copolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev: CD002851.
26. Jiang ZL, Shen HM, Yang K, Jin SY, (1999) Observation of the effect of ginger and Ach-receptor inhibitors on simulated motion sickness in rats. Chin J Naut Med6: 20-22.